| Food Quality and Safety Studies | Lifetime | 66 | KR 19 | 98.94 |
| Ginseng Biological Effects and Applications | Lifetime | 53 | KR 6 | 98.78 |
| Pharmacological Effects of Natural Compounds | Lifetime | 163 | KR 11 | 98.61 |
| Natural product bioactivities and synthesis | Lifetime | 467 | KR 37 | 97.83 |
| Natural Antidiabetic Agents Studies | Lifetime | 267 | KR 13 | 97.33 |
| Traditional Chinese Medicine Analysis | Lifetime | 285 | KR 10 | 95.99 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 97 | KR 2 | 95.49 |
| Ginger and Zingiberaceae research | Lifetime | 143 | KR 9 | 93.64 |
| Phytoestrogen effects and research | Lifetime | 814 | KR 37 | 90.65 |
| Bioactive natural compounds | Lifetime | 425 | KR 55 | 89.66 |
| Ginkgo biloba and Cashew Applications | Lifetime | 412 | KR 8 | 86.75 |
| Phytochemical compounds biological activities | Lifetime | 970 | KR 23 | 88.01 |
| Ziziphus Jujuba Studies and Applications | Lifetime | 216 | KR 12 | 80.51 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 600 | KR 16 | 75.38 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 680 | KR 25 | 77.94 |
| Silymarin and Mushroom Poisoning | Lifetime | 415 | KR 15 | 75.22 |
| Sesame and Sesamin Research | Lifetime | 665 | KR 23 | 65.82 |
| Natural product bioactivities and synthesis | 2021-2025 | 74 | KR 2 | 95.72 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 240 | KR 1 | 91.02 |
| Ginseng Biological Effects and Applications | 2021-2025 | 135 | KR 11 | 89.32 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 431 | KR 26 | 86.45 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 630 | KR 30 | 84.73 |
| Fungal Biology and Applications | 2021-2025 | 653 | KR 7 | 84.89 |
| Bioactive natural compounds | 2021-2025 | 72 | KR 8 | 79.96 |
| Ginger and Zingiberaceae research | 2021-2025 | 137 | KR 3 | 80.22 |
| Skin Protection and Aging | 2021-2025 | 427 | KR 51 | 84.02 |
| Biological Activity of Diterpenoids and Biflavonoids | 2021-2025 | 75 | KR 2 | 78.56 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 1,000 | KR 40 | 74.71 |
| Pharmacology and Obesity Treatment | 2021-2025 | 378 | KR 7 | 76.21 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 515 | KR 8 | 70.09 |
| Phytoestrogen effects and research | 2021-2025 | 467 | KR 49 | 62.93 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 772 | KR 21 | 62.21 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 333 | KR 15 | 59.53 |
| Phytochemistry and Bioactive Compounds | 2021-2025 | 296 | KR 7 | 55.37 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 952 | KR 46 | 53.91 |
| Silymarin and Mushroom Poisoning | 2021-2025 | 216 | KR 12 | 46.81 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 751 | KR 11 | 39.93 |
| Medicinal Plant Pharmacodynamics Research | 2021-2025 | 268 | KR 1 | 40.43 |
